Clinical Trial Update: Vorinostat Before Surgery in Treating Patients With Triple-Negative Breast Cancer [NA]

View source ↗

Summary

The clinical trial evaluating vorinostat before surgery for Stage II/IIIA breast cancer, including triple-negative breast cancer, has been withdrawn. The sponso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• Vorinostat (vorinostat)

Snippet

Sponsor: University of Southern California | Conditions: Stage II Breast Cancer, Stage IIIA Breast Cancer | NA | Status: WITHDRAWN